Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
Dr. Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr. Cho has conducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics.
Dr. Cho has published over 500 SCI peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications, PNAS, Molecular Cancer, Journal of Thoracic Oncology, Journal of the National Cancer Institute, Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Theranostics, etc) covering cancer biomarkers, proteomics, non-coding RNAs, Chinese medicine and dozens of books including “An Omics Perspective on Cancer Research”, “MicroRNAs in Cancer Translational Research”, “Drug Repurposing in Cancer Therapy: Approaches and Applications” and “Supportive Cancer Care with Chinese Medicine” etc. The accumulated impact factors of the journals over 3,600 and these papers have received > 23,000 citations.
In addition, Dr. Cho has also served as a research grant reviewer for many international research funds, including the Hope Funds for Cancer Research (United States), National Medical Research Council (Singapore), etc.